
|
For
immediate release -- Monday, July 2, 2001.
Contact: Bob Brammer at 515-281-6699
|
|
Iowa
Joins Antitrust Suit Alleging Prescription Drug Maker Illegally Blocked
Generic Version of Popular
Blood Pressure Medication
Twenty-seven states
including Iowa have joined in an antitrust lawsuit today alleging that
two major pharmaceutical companies illegally conspired to keep off the
market a generic form of the popular heart medication called "Cardizem
CD."
The suit alleges that
the Hoechst pharmaceutical company, the maker of Cardizem CD, paid Andrx
Corp. about $90 million to keep a lower-priced generic version of Cardizem
off the market for about a year beginning in 1998. Cardizem CD is considered
a highly effective medication for high blood pressure, chest pains and
heart disease. Defendants in the suit are Andrx and French-based Aventis
SA, which acquired Hoechst last year.
The suit says the
states are seeking relief "for a series of anti-competitive acts
by which defendants sought to delay or prevent the marketing of less expensive,
generic alternatives to Cardizem CD, a highly profitable, brand-name drug."
The States are asking
the court to order restitution for consumers and taxpayer-financed programs
like Medicaid. The suit was filed in the U.S. District Court for the Eastern
District of Michigan.
"We are very
concerned about any anti-competitive conduct that drives up the cost of
prescription drugs for senior citizens or anyone else." Miller said.
"In addition to being a financial burden, it's a health issue. Some
people stop taking needed medications when prices go too high."
State Attorneys General
have estimated that a million Americans take Cardizem CD or its generic
versions. Generic versions now are sold at about half the price of Cardizem
CD, which now costs about $65 per month for a typical dosage. "It
is damaging to citizens and taxpayers when people have to pay more for
an expensive brand-name drug when a lower-priced generic should be available
as an alternative," Miller said.
Twenty-seven states
plus the District of Columbia and Puerto Rico have joined in the suit:
AK, AZ, AR, CA, CT, DC, HI, ID, IN, IA, KS, ME, MI, MN, NV, NM, NY, NC,
ND, OK, PR, RI, SC, UT, VT, WA, WV, WI, WY. The NY and MI State Attorneys
General Offices are serving as lead counsel for the states.
- 30
-
|